Department of Anesthesiology and Pain Medicine, Korean Institute of Radiological & Medical Sciences, Seoul, Korea.
Korean J Anesthesiol. 2010 Sep;59(3):214-9. doi: 10.4097/kjae.2010.59.3.214. Epub 2010 Sep 20.
The percutaneous placement of a totally implantable vascular access port via the subclavian vein is commonly used in patients with a need for multiple intravenous infusions such as administration of chemotherapy. Unfortunately, the use of central venous ports have been associated with adverse events that are hazardous to patients. Here we report the case of a 5-year-old child who died of catastrophic hemothorax after several attempts at insertion of an implantable subclavian venous access device and removal of an infected port. Massive hemothorax occurred on the side contralateral to unsuccessful attempts at insertion of a new port and ipsilateral to the removal of an infected port. We could not confirm the cause of death and hemothorax without autopsy, but we discuss several possible causes of massive hemothorax.
经锁骨下静脉经皮植入完全植入式血管通路端口在需要多次静脉输注的患者中(如化疗给药)通常会用到。不幸的是,中心静脉置管与对患者有危险的不良事件有关。在此,我们报告了一例 5 岁儿童的病例,该儿童在多次尝试插入植入式锁骨下静脉通路装置和取出感染的端口后死于灾难性血胸。大量血胸发生在新端口插入不成功的对侧和感染端口取出的同侧。未经尸检,我们无法确定死亡和血胸的原因,但我们讨论了大量血胸的几种可能原因。